ANIMAL GENETICS, published by WILEY, is a leading journal in the fields of Animal Science and Zoology, with a commendable Q1 classification for 2023, reflecting its critical role in advancing research and knowledge in animal genetics. Established in 1986, this journal has become a cornerstone for professionals, researchers, and students alike, providing a platform for innovative research that explores the genetic underpinnings of animal biology. With an ISSN of 0268-9146 and an E-ISSN of 1365-2052, it boasts a significant impact in both agricultural and biological sciences, as indicated by its ranking of #74 out of 490 in its category on Scopus, positioning it in the 85th percentile for Animal Science and Zoology. Readers can access high-quality, peer-reviewed articles that not only illuminate current advancements but also foster future research directions. While currently not an open access journal, ANIMAL GENETICS remains vital for anyone engaged in the exploration of genetics and its applications in medicine and beyond, with a continual commitment to publishing findings that shape the future of animal breeding, conservation, and genetics research.

Journal of Pediatric Genetics, published by GEORG THIEME VERLAG KG, is an essential resource in the field of pediatric medicine and genetics. With a focus on the genetic determinants of health and disease in children, this journal aims to advance the knowledge and application of genetic research in pediatric care. Although it has faced challenges in its indexing in recent years, it provides an important platform for practitioners and researchers dedicated to understanding the complexities of pediatric genetics. As evidenced by its position in Scopus ranks—ranked #209 in Pediatrics and #87 in Clinical Genetics—the journal serves a niche yet critical audience seeking to explore the interplay between genetic factors and childhood health outcomes. The Journal of Pediatric Genetics invites scholars and professionals to delve into its rich content, contributing to the ongoing discourse in this vital field, while the absence of open access highlights the journal’s curation of high-quality, peer-reviewed articles that are valued across academia and clinical practices.

Welcome to the Journal of Human Genetics, a premier publication in the field of human genetics, published by SpringerNature. With a commitment to sharing groundbreaking research, this journal has been at the forefront of genetic studies since its establishment in 1961, converging its focus in 1996 and continuing to evolve through 2024. It holds a respected Q2 ranking in both the Genetics and Clinical Genetics categories, reflecting its significant contribution to the scientific community. With a notable Scopus ranking of 23rd out of 99 in Clinical Genetics and 95th out of 347 in Genetics, the journal offers a platform for high-impact research that informs clinical practices and advances the understanding of genetic disorders. Operating under an open-access model, it ensures that findings are readily accessible to researchers, professionals, and students worldwide. Join us in exploring the complexities of human genetics and contribute to the ongoing discourse in this dynamic field.

The European Thyroid Journal, published by BIOSCIENTIFICA LTD, is a premier open-access journal that has been delivering high-quality research in the field of endocrinology since its inception. With an ISSN of 2235-0640 and an E-ISSN of 2235-0802, this journal serves as a vital resource for researchers, clinicians, and students focused on the latest developments in thyroid disease, diagnosis, and treatment. Located in Switzerland and currently enjoying a Q2 ranking in the Endocrinology, Diabetes, and Metabolism category for 2023, it ranks an impressive 71st out of 244 journals in its field, underscoring its significant impact, as evidenced by its substantial impact factor. The journal’s commitment to open access since 2022 enhances its accessibility and reach, ensuring that groundbreaking findings are disseminated swiftly and widely. By bridging knowledge across the endocrine research community, the European Thyroid Journal plays an instrumental role in advancing the understanding and management of thyroid-related disorders, making it an invaluable asset for anyone involved in this critical area of health.

AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS is a premier peer-reviewed journal published by Wiley, focusing on the intricate and evolving field of medical genetics. With its ISSN 1552-4868 and E-ISSN 1552-4876, the journal has established itself as a significant resource for researchers, professionals, and students alike, addressing cutting-edge developments in genetic research and clinical practice. Ranked in the top quartile (Q2) in both Genetics and clinical Genetics categories for 2023, it maintains an impressive Scopus ranking, positioning it within the 75th and 71st percentiles for Medicine and Genetics respectively. The journal encourages open access to its content, promoting wider dissemination of knowledge and fostering collaboration among medical genetics experts. From its inaugural issues in 1980 to its ongoing publications, the journal aims to bridge the gap between genetics research and its clinical applications, providing insights that reflect the latest advancements in the field. As it continues to serve the global medical community, the AMERICAN JOURNAL OF MEDICAL GENETICS PART C remains a vital source for those seeking to understand the complexities of genetic disorders and their implications for health and disease.

ACTA BIOCHIMICA POLONICA (ISSN: 0001-527X, E-ISSN: 1734-154X) is a distinguished journal published by the ACTA BIOCHIMICA POLONICA in Poland, with a rich history dating back to 1955. As a prominent platform for disseminating research, it currently holds a Category Quartile of Q3 in the fields of Biochemistry, Genetics, and Molecular Biology, reflecting its commitment to advancing knowledge in these critical areas. This journal is indexed in Scopus, ranking 124 out of 221, placing it in the 44th percentile among general biochemistry, genetics, and molecular biology journals. Although it does not operate under an open-access model, ACTA BIOCHIMICA POLONICA remains a vital resource for researchers, professionals, and students seeking to delve into the latest developments and discoveries in biochemistry and molecular biology. Its strategic focus on contemporary topics ensures that it plays an essential role in shaping future scientific inquiries and fostering collaboration across various disciplines.

CLINICAL GENETICS is a premier journal in the field of genetics, published by Wiley, and is renowned for advancing the understanding of genetic disorders and their clinical applications. With a notable impact factor and ranking in the top quartile (Q1) in both general genetics and clinical genetics as of 2023, this journal is instrumental for researchers, professionals, and students seeking to explore groundbreaking studies and developments in genetics. Since its inception in 1970, CLINICAL GENETICS has continued to publish high-quality, rigorously peer-reviewed research that pushes the boundaries of knowledge in clinical genetics. The journal maintains a strong reputation in its field, currently holding significant positions in Scopus rankings, including 30th out of 99 in clinical genetics, underscoring its relevance and impact in the field. For those interested, the journal's website provides comprehensive access options for current and archived research, making it an essential resource for anyone involved in genetic research and its clinical application.

Molecular Genetics & Genomic Medicine, published by WILEY, is an esteemed and open-access journal that has been a prominent source of knowledge in the fields of genetics and molecular biology since its establishment in 2013. With an ISSN of 2324-9269, it aims to provide a platform for the dissemination of novel findings and innovative research that pushes the boundaries of genomics and its clinical applications. The journal holds a Q3 categorization in Genetics, Clinical Genetics, and Molecular Biology, reflecting its growing influence in these disciplines, as evidenced by its Scopus rankings. Researchers, professionals, and students alike will find valuable insights and advancements in genomic medicine, making this journal an essential resource for those dedicated to the understanding and application of genetic and molecular research in healthcare. Located at 111 River St, Hoboken, NJ, Molecular Genetics & Genomic Medicine continues to foster a global dialogue within the scientific community, ensuring accessible knowledge for all.

CLINICAL ENDOCRINOLOGY, published by Wiley, is a premier journal in the field of endocrinology, providing a vital platform for the dissemination of cutting-edge research and advancements in the diagnosis and treatment of endocrine disorders. Since its inception in 1972, this prestigious journal has maintained its commitment to excellence with its scope encompassing diverse areas within endocrinology, diabetes, and metabolism, evidenced by its impressive ranking in the Q2 quartile for these categories as of 2023. With a growing impact factor, it serves as a leading reference for researchers and healthcare professionals dedicated to improving patient outcomes. Although the journal does not currently offer open access, it remains accessible through institutional subscriptions, ensuring that vital research reaches an expansive audience. Its robust focus on clinical applications makes CLINICAL ENDOCRINOLOGY an essential resource for anyone involved in the evolving field of endocrinology, thereby underscoring its importance in shaping future research and practice in healthcare.

OPHTHALMIC GENETICS is a distinguished journal published by TAYLOR & FRANCIS INC, specializing in the intersection of genetics and ophthalmology. Established in 1981, the journal has become a vital resource for researchers, clinicians, and students interested in the genetic aspects of eye diseases and disorders. Despite not being an Open Access journal, it maintains a commendable impact within the academic community, as reflected by its Q3 ranking in clinical genetics and Q2 rankings in both ophthalmology and pediatrics in 2023. With a robust focus on clinical applications, OPHTHALMIC GENETICS aims to provide a platform for innovative research and insights that drive advancements in patient care and understanding of genetic conditions affecting vision. The journal's international readership is supported by its timely publication of articles that bridge the gap between genetic research and practical ophthalmological applications.